Relugolix
A na-eji Relugolix agwọ ọrịa cancer prostate dị elu (cancer nke na-amalite na prostate [a nwoke na-amụ nwa)) na ndị okenye. Relugolix nọ na klas nke ọgwụ a na-akpọ gonadotropin-na-ahapụ homonụ (GnRH) antagonists. Ọ na-arụ ọrụ site n'ibelata ọnụọgụ testosterone (hormone nwoke) nke ahụ na-emepụta. Nke a nwere ike belata ma ọ bụ kwụsị mgbasa nke mkpụrụ ndụ kansa prostate nke chọrọ testosterone iji too.
Relugolix na-abịa dị ka mbadamba nkume iji ọnụ were were. A na-ewerekarị ya ma ọ bụ na-ejighị nri otu ugboro kwa ụbọchị. Were relugolix n'otu oge kwa ụbọchị. Soro ntuziaka dị na akara ndenye gị nke ọma, ma jụọ dọkịta gị ma ọ bụ onye na-ere ọgwụ ka ọ kọwaa akụkụ ọ bụla ị ghọtaghị. Were relugolix kpọmkwem dị ka a gwara ya. Ejila ya karịa ma ọ bụ obere ma ọ bụ were ya ugboro ugboro karịa ka dọkịta gị kwuru.
Ozi MedlinePlus naRelugolix- Nchịkọta asụsụ nkịtị nke ozi dị mkpa gbasara ọgwụ a nwere ike ịgụnye ihe ndị a:
- ● ịdọ aka ná ntị banyere ọgwụ a,
- ● ihe a na-eji ọgwụ a eme ihe na otu esi eji ya,
- ● ihe i kwesịrị ịgwa dọkịta gị tupu ị na-aṅụ ọgwụ a,
- ● ihe i kwesịrị ịma gbasara ọgwụ a tupu ị were ya,
- ● ọgwụ ndị ọzọ nwere ike iji ọgwụ a emekọrịta ihe, na
- ● Mmetụta ndị nwere ike ime.
A na-amụkarị ọgwụ ọjọọ iji chọpụta ma ha nwere ike inye aka ịgwọ ma ọ bụ gbochie ọnọdụ ndị ọzọ karịa nke a kwadoro ha. Mpempe akwụkwọ ozi onye ọrịa a na-emetụta naanị maka ojiji ọgwụ akwadoro. Agbanyeghị, ọtụtụ n'ime ozi a nwekwara ike metụta ojiji a na-akwadoghị nke a na-amụ.





Atụmatụ18Arụmọrụ ntule na-agbanwe agbanwe nke akwadoro4, na6oru ngo na-akwado.

Usoro njikwa ogo mba ụwa dị elu etinyela ntọala siri ike maka ire ahịa.

Nlekọta dị mma na-aga n'ihu na usoro ndụ nke ngwaahịa ahụ niile iji hụ na ịdị mma na mmetụta ọgwụgwọ.

Ndị otu Regulatory Affairs ndị ọkachamara na-akwado ịdịmma chọrọ n'oge ngwa na ndebanye aha.


Ahịrị nkwakọ ngwaahịa Korea Countec


Taiwan CVC ahịrị nkwakọ ngwaahịa


Line CAM Board nke Italy

Igwe na-agbakọ Fette German

Ihe nchọpụta mbadamba ihe ngosi nke Japan

Ụlọ njikwa DCS

